Perini, G. F. Et Al. 2023. BELLWAVE-003: A phase 2 dose escalation, confirmation, and cohort expansion study of nemtabrutinib in hematologic malignancies.. JOURNAL OF CLINICAL ONCOLOGY , vol.41, no.16 .

Perini, G. F., Owen, C., Ozcan, M., Jurczak, W., Barca, E. G., Wrobel, T., ... Lavie, D.(2023). BELLWAVE-003: A phase 2 dose escalation, confirmation, and cohort expansion study of nemtabrutinib in hematologic malignancies.. JOURNAL OF CLINICAL ONCOLOGY , vol.41, no.16.

Perini, Guilherme Et Al. "BELLWAVE-003: A phase 2 dose escalation, confirmation, and cohort expansion study of nemtabrutinib in hematologic malignancies.," JOURNAL OF CLINICAL ONCOLOGY , vol.41, no.16, 2023

Perini, Guilherme F. Et Al. "BELLWAVE-003: A phase 2 dose escalation, confirmation, and cohort expansion study of nemtabrutinib in hematologic malignancies.." JOURNAL OF CLINICAL ONCOLOGY , vol.41, no.16, 2023

Perini, G. F. Et Al. (2023) . "BELLWAVE-003: A phase 2 dose escalation, confirmation, and cohort expansion study of nemtabrutinib in hematologic malignancies.." JOURNAL OF CLINICAL ONCOLOGY , vol.41, no.16.

@article{article, author={Guilherme Fleury Perini Et Al. }, title={BELLWAVE-003: A phase 2 dose escalation, confirmation, and cohort expansion study of nemtabrutinib in hematologic malignancies.}, journal={JOURNAL OF CLINICAL ONCOLOGY}, year=2023}